Jennifer Nagel

Statistics

Publications

Citations

877

H-Index

Active since

2005

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

McGill University

Inserm

Hôpital Gui de Chauliac

Jennifer Nagel is an author at Novartis (Switzerland) specializing in pharmacotherapy, dementia pharmacotherapy, and pharmacological treatment of dementia.

Publications per year

2005–2013

Publications

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule

Bengt Winblad, Jeffrey L. Cummings, Niels Andreasen et al. · International Journal of Geriatric Psychiatry · 2007 · 284 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

Roger Bullock, Jacques Touchon, Howard Bergman et al. · Current Medical Research and Opinion · 2005 · 230 citations

Medicine, Pharmacology, Pharmacotherapy +12

AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study

Fabrizio Stocchi, Olivier Rascol, A. Destée et al. · Movement Disorders · 2013 · 137 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease

Rafael Blesa, Roger Bullock, Yunsheng He et al. · Pharmacogenetics and Genomics · 2006 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease

Roger Bullock, Howard Bergman, Jacques Touchon et al. · Current Medical Research and Opinion · 2006 · 63 citations

Medicine, Neurology, Pharmacotherapy +17

1–5 of 7